M61.175
Myositis ossificans progressiva, left foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Myositis ossificans progressiva (MOP) of the left foot is a rare and serious condition characterized by abnormal bone formation within the muscles and soft tissues of the foot. This progressive disorder leads to joint stiffness, deformity, and loss of function, significantly impacting mobility and quality of life. Early understanding of the condition and its progression can aid in managing symptoms and planning appropriate treatment strategies.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting bone growth regulation, often inherited in an autosomal dominant pattern. Trauma or injury to the foot or surrounding tissues, which may trigger abnormal bone formation. Certain medical conditions and syndromes associated with abnormal ossification processes. Environmental factors or unknown causes, given the rarity of the disease.
Key Symptoms: Progressive stiffness and swelling in the affected area of the foot. Visible or palpable hardened masses within muscles and soft tissues. Decreased range of motion in joints of the foot and ankle. Deformities of the toes and foot structure as the condition progresses. Pain or discomfort during movement, although some cases may be asymptomatic initially. Potential difficulty walking or bearing weight due to structural changes.
Diagnostic & Treatment
Diagnosis Path: Diagnosis is based on a combination of clinical assessment, imaging studies, and genetic testing. Medical professionals may utilize the following tools:
Treatment Protocols: There is no cure for myositis ossificans progressiva; management focuses on controlling symptoms and preventing complications. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is M61.175 a billable ICD-10 code?
Yes, M61.175 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M61.175?
Clinical documentation must specify the nature of Myositis ossificans progressiva, left foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference